Mutual Fund Ownership
Ownership as on: Mon, 4 Mar, 2024

WhiteOak Capital Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)4.52
% of AUM5.31%

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)45.70
% of AUM4.97%

HDFC Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)32.20
% of AUM4.40%

Samco Active Momentum Fund Regular Growth

NA
Equity
Amount Invested (Cr.)21.82
% of AUM4.04%

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)8.63
% of AUM3.44%

FAQs about Ajanta Pharmaceuticals share price

Ajanta Pharmaceuticals is trading at 2105.95 as on Mon Mar 04 2024 07:46:36. This is -1.40% lower as compared to its previous closing price of 2135.80.

The market capitalization of Ajanta Pharmaceuticals is 26517.21 Cr as on Mon Mar 04 2024 07:46:36.

The average broker rating on Ajanta Pharmaceuticals is Buy. The breakup of analyst rating is given below -

  • 5 analysts have given a strong buy rating
  • 3 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 2 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Ajanta Pharmaceuticals is 2355.05 whereas the 52 wk low is 1126.92

Ajanta Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 35.76
  • Sector P/E: 21.77
  • Dividend Yield: 0.80%
  • D/E ratio: -

Ajanta Pharmaceuticals reported a net profit of 587.98 Cr in 2023.

Recommended For You
Images
Trending Stocks
355.20+13.35(3.91%)
3,002.00+21.15(0.71%)
1,928.20-32.85 (-1.68%)
153.25-1.90 (-1.22%)